Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication

Nature·Sep 27

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research suggests that inhibiting fatty acid synthesis may block the replication of SARS-CoV-2. Studies have identified various potential targets for therapeutic development, including lipid metabolism and host-targeted pathways. The intersection of lipid metabolism, immune response, and viral infection is being explored as a possible approach to developing broad-spectrum antiviral treatments.

Full coverage

Dual antiviral and anti-inflammatory effects of BAY 11-7082 in SARS-CoV-2 infection via inhibition of the canonical NF-κB signaling pathway

Nature·Apr 16

Mammalian fatty acid synthase: a commonly used viral host dependency factor and a putative target for host-targeted broad-spectrum antiviral therapeutic development

ASM Journals·Jun 25

Lipid compartments and lipid metabolism as therapeutic targets against coronavirus

Frontiers·Dec 1

Lipid metabolism, viral infection, and antiviral immunity: a new host-pathogen interface

Frontiers·Feb 11

Therapeutic strategy targeting host lipolysis limits infection by SARS-CoV-2 and influenza A virus

Nature·Oct 17

The diverse interaction of metabolism, immune response, and viral pathogens

Frontiers·Jul 28

A portrait of the infected cell: how SARS-CoV-2 infection reshapes cellular processes and pathways

Nature·Dec 17

The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2

Frontiers·Feb 12

View original report at Nature ↗

Fetching the latest headlines…